12.5 "

: Sutent 12.5 Mg. ?  »
|
-

PER OS

Capsules

Sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. Sutent is indicated for the treatment of advanced renal cell carcinoma.Treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.

136 89 31430 00

Pfizer Italia S.r.l., Italy

06/2012 - 06/2022

.
, .
.
/
Sunitinib as malate 12.5 MG
Blister pvc/aclar/aluminium 7 x CAPSULES 36
Blister pvc/aclar/aluminium 14 x CAPSULES 36
Blister pvc/aclar/aluminium 21 x CAPSULES 36
Blister pvc/aclar/aluminium 28 x CAPSULES 36
Blister pvc/aclar/aluminium 56 x CAPSULES 36
Bottle hdpe 28 x CAPSULES 36
Bottle hdpe 30 x CAPSULES 36

*

*

 

.

? !
 »
 
" !
 

?

!
!
 »
278
,